期刊文献+

反相高效液相色谱法测定酒石酸托特罗定分散片含量 被引量:1

CONTENT DETERMINATION OF TOLTERODINE TARTRATE DISPERSIBLE TABLETS BY RP-HPLC
下载PDF
导出
摘要 目的建立反相高效液相色谱法测定酒石酸托特罗定分散片中酒石酸托特罗定的含量。方法色谱柱为岛津公司C18色谱柱(2507mm×4.67mm,5μm);流动相:乙腈-0.59磷酸溶液(pH7.4),检测波长为282聊,流速为1.0ml·min-1,柱温为30U。结果酒石酸托特罗定在0.1013~1.0130mg·ml-1范围内线性关系良好,r=0.9995,平均回收率为99.79,RSD为0.88%(n=9)。结论该方法简便、快捷、重现性好、准确度高。 Objective To explore the effect of reverse phase-high performance liquid chromatography(RP-HPLC) on content determination of tolterodine tartrate dispersible tablets. Methods The chromatographic system consisted of C18 (250 mm×4.67mm,5μm). The mobile phase included acetonitrile-0.5% phosphoric acid solution (with the pH value being 7.4), a detection wave length of 282 nm, the flow rate of 1 ml · min-1, with the temperature at 30℃. Results The content determination got good results when the linear range was 0. 1013 -1.0. 130 mg. ml-l(r = 0. 9995), with the average recovery rate being 99.7% and the RSD was 0.88%(n = 9). Conclusion RP-HPLC an be effectively used easily, accurately and reproducibly for the content determination of tolterodine tartrate dispersible tablets.
作者 刘红云
出处 《山东医学高等专科学校学报》 2013年第4期301-302,共2页 Journal of Shandong Medical College
关键词 反相高效液相色谱法 酒石酸托特罗定分散片 含量测定 Reverse phase-high performance liquid chromatography Tolterodine tartrate dispersible tablet Content determination
  • 相关文献

参考文献2

二级参考文献10

  • 1彭永富,董慧.药物溶出度Weibul分布的计算机求解[J].中国药学杂志,1996,31(10):606-608. 被引量:58
  • 2姚亚杰.尿失禁治疗药托特罗定(tolterodine)[J].国外医药合成药生化药制剂分册,2000,21(1):23-23.
  • 3Yarker YE,Guo KL,Fitton A.Oxybutinin:a review of its pharmacodynamic and phannacokinetic properties,and its therapeutic use in detrusor instability[J].Drug Aging,1995; 6:243-262.
  • 4Nilvebrant L,Gillberg PG,Sparf B.Antimuscarinic potency and bla dder selectivity of PNU-200577,a major metabolite of tolterodine[J].Pharmacol Toxicol,1997; 81:169-172.
  • 5Nilvebrant L,Andersson KE,Gillberg PG.Tolterodine-a new bla dder selective antimuscarinic agent[J].Eur J Pharmacol,1997; 327:195-207.
  • 6Olsson B,Szamosi J.Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine[J].Clin Pharmacokinet,2001; 40:227-235.
  • 7Takei M,Homma Y.Long-term safety,tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder in Japanese patients[J].Int J Urol,2005; 12:456-464.
  • 8陈幼亭.威布尔分布函数处理溶出数据应注意的问题[J].中国医院药学杂志,1998,18(9):419-420. 被引量:40
  • 9段继宏,杨勇,吴士良,潘柏年,那彦群,薛兆英,郭应禄.北京地区尿失禁发病率调查[J].北京医科大学学报,2000,32(1):74-75. 被引量:237
  • 10吴士良,崔一民,杨勇,段继宏,那彦群,徐祗顺,程继义,蔡松良,秦大山,孙玉成,郭应禄.酒石酸托特罗定与奥昔布宁双盲双模拟随机对照治疗膀胱过度活动症多中心临床研究[J].中国临床药理学杂志,2001,17(5):337-340. 被引量:7

共引文献13

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部